Literature DB >> 9313885

Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation.

S Hibi1, K Tsunamoto, S Todo, T Sawada, Y Ueda, M Taniwaki, M Naya, M Hojo, S Imashuku.   

Abstract

To evaluate the chimeric status of mononuclear cells in the CSF after allogeneic BMT, cells were analyzed by FISH using satellite DNA probes for human X and Y chromosomes. CSF cells were obtained from five pediatric ALL patients who received BMT from sex-mismatched donors. All patients received TBI-containing conditioning regimens. We found that CSF cells showed complete donor type in 19-97 days after BMT, when complete donor type hematopoiesis was observed. The rapid entry of the donor leukocytes into the brain may exert beneficial effects to eradicate the residual CNS leukemic cells and prevent a CNS relapse in ALL patients after BMT.

Entities:  

Mesh:

Year:  1997        PMID: 9313885     DOI: 10.1038/sj.bmt.1700918

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Donor cell chimerism evaluation in cerebrospinal fluid by short tandem repeat analysis following allogeneic hematopoietic stem cell transplantation.

Authors:  Jessica L Spruit; Omar R Fagoaga; Süreyya Savaşan
Journal:  Hum Immunol       Date:  2018-04-11       Impact factor: 2.850

Review 2.  Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines.

Authors:  Joaquim Vives; Aina Casademont-Roca; Lluís Martorell; Núria Nogués
Journal:  Bone Marrow Transplant       Date:  2020-02-05       Impact factor: 5.483

3.  Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation.

Authors:  M Waterhouse; I Bartsch; H Bertz; J Duyster; J Finke
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

4.  Combined immunoradiotherapy induces long-term remission of CNS relapse of peripheral, diffuse, large-cell lymphoma after allogeneic stem cell transplantation: case study.

Authors:  Christian Lotze; Frank Schüler; William H Krüger; Carsten Hirt; Michael Kirsch; Silke Vogelgesang; Christian A Schmidt; Gottfried Dölken
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

5.  Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation.

Authors:  Christoph Busemann; Andrej Gudzuhn; Carsten Hirt; Michael Kirsch; Silke Vogelgesang; Christian A Schmidt; Gottfried Dölken; William H Krüger
Journal:  Exp Hematol Oncol       Date:  2012-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.